HC, T., KC, W., PY, C., CY, H., KT, C., YJ, L., . . . HT, W. (2021). Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway. Frontiers in oncology, 11, 722754. https://doi.org/10.3389/fonc.2021.722754
Chicago Style (17th ed.) CitationHC, Tsai, Wei KC, Chen PY, Huang CY, Chen KT, Lin YJ, Cheng HW, Chen YR, and Wang HT. "Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the P53-PUMA Apoptosis Pathway." Frontiers in Oncology 11 (2021): 722754. https://doi.org/10.3389/fonc.2021.722754.
MLA (9th ed.) CitationHC, Tsai, et al. "Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the P53-PUMA Apoptosis Pathway." Frontiers in Oncology, vol. 11, 2021, p. 722754, https://doi.org/10.3389/fonc.2021.722754.